Can we develop ethically universal embryonic stem-cell lines?

Nature Reviews Genetics

Volumn 8, Issue 6, 2007, Pages 480-485

  Green, Ronald M ^a  

^a DARTMOUTH COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY TECHNIQUE; BIOTECHNOLOGY; BLASTOMERE; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS TRANSPLANTATION; CHROMOSOME ABERRATION; EMBRYONIC STEM CELL; ETHICAL THEORY; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; NONHUMAN; PARTHENOGENESIS; PRIORITY JOURNAL; REVIEW; SOMATIC CELL;

BLASTOMERES; CELL DIFFERENTIATION; CELL LINE; CHROMOSOME ABERRATIONS; CLONING, ORGANISM; CYTOLOGICAL TECHNIQUES; DEATH; EMBRYONIC STEM CELLS; HUMANS; NUCLEAR TRANSFER TECHNIQUES; PARTHENOGENESIS; PREIMPLANTATION DIAGNOSIS;

EID: 34249011489     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2066     Document Type: Review

References (37)

1. Liao, S. M. Rescuing human embryonic stem cell research: the blastocyst transfer method. Am. J. Bioeth. 5, 8-16, (2005).
2. Walters, L. Human embryonic stem cell research: an intercultural perspective. Kennedy Inst. Ethics J. 14, 3-38 (2004).
3. European Parliament. €54 billion boost for EU scientific research 2007-2013 [online], 〈http://www.europarl.europa.eu/news/expert/ thematic_note_page/057-897-345-12-50-909-20061201TMN00896-11-12-2006-2006/ default_p001c004_en.htm〉 (2006).
4. Kaljuvee, A. Blind faith vs. science. Ego (9 August 2006) [online], 〈http://www.egothemag.com/archives/2006/08/stem_cells_blin. htm〉 (2006).
5. OECD Health Division. Expenditure on health-related functions: Public expenditure on health R&D, 10 October 2006. [online], 〈http://www.ecosante.fr//index2.php?base=OCDE&langs=ENG&langh= ENG&ref=YES&sessionid=854165d64e449b646cb6aa e713bf740d〉 (2006).
6. Green, R. M. Benefiting from 'evil': an incipient moral problem in human stem cell research. Bioethics 16, 544-556 (2002).
7. Williams, C. The Campaign For Ethical Vaccines: Alternatives to vaccines made from aborted babies [online], 〈http://www.dgwsoft.co.uk/ homepages/vaccines/alternatives.htm〉 (2002).
8. Sgreccia, E. Moral reflections on vaccines prepared from cells derived from aborted human fetuses. Pontificia Academia Pro Vita (Pontifical Academy for Life), Vatican City (9 June 2005) [online], 〈http://www.cogforlife. org/vaticanresponse.htm〉 (2005).
9. Wagers, A. & Weissman, I. L. Plasticity of adult stem cells. Cell 116, 639-648 (2004).
10. Schwartz, R. S. The politics and promise of stem-cell research. N. Eng. J. Med. 355, 1189-1191 (2006).
11. De Coppi, P. et al. Isolation of amniotic stem cell lines with potential for therapy. Nature Biotechnol. 25, 100-106 (2007).
12. Hurlbut, W. B. Altered nuclear transfer as a morally acceptable means for the procurement of human embryonic stem cells. Commissioned working paper for the President's Council on Bioethics December 2004 meeting [online], 〈http://www.bioethics.gov/background/hurlbut.html〉 (2004).
13. Hurlbut, W. B. Statement of Dr. Hurlbut in President's Council on Bioethics, Human Cloning and Human Dignity 267-276 [online], 〈http://bioethics.gov/reports/cloningreport/pcb_cloning_report.pdf〉 (2002).
14. Meissner, A. & Jaenisch, R. Generation of pluripotent NT-ES cells from cloned Cdx2 deficient blastocysts. Nature 439, 212-215 (2006).
15. Kiessling, A. A. In the stem-cell debate, new concepts need new words. Nature 413, 453 (2001).
16. Melton, D. A., Daley, G. Q. & Jennings, C. G. Altered nuclear transfer in stem-cell research - a flawed proposal. N. Eng. J Med. 351, 2791-2792 (2004).
17. Kass, L. The wisdom of repugnance: why we should ban the cloning of humans New Repub. 216, 17-26 (1997).
18. United Nations. Declaration on Human Cloning. August 3, 2005. [online], 〈http://www.unesco.ru/files/docs/shs/declaration_on_cloning_eng.pdf〉 (2005).
19. Crockin, S. Challenges of stem-cell research. Boston Globe (12 December 2006).
20. Kim, K. et al. Histocompatible embryonic stem cells by parthenogenesis. Science 315, 482-486 (2007).
21. Vrana, K. E. et al. Nonhuman primate parthenogenetic stem cells. Proc. Natl Acad. Sci. USA 100, 11911-11916 (2003).
22. Landry, D. W. & Zucker, H. A. Embryonic death and the creation of human embryonic stem cells. J. Clin. Invest. 114, 1184-1186 (2004).
23. Munné, S. et al. Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. Fert. Steril. 84, 1328-1334 (2005).
24. Verlinsky, Y. et al. Over a decade of experience with preimplantation genetic diagnosis: a multicenter report. Fertil. Steril. 82, 292-294, (2004).
25. Chung, Y. et al. Embryonic and extraembryonic stem cell lines derived from single mouse blastomeres. Nature 439, 216-219 (2006).
26. Klimanskaya, I., Chung, Y., Becker, S., Lu, S. & Lanza, R. Human embryonic stem cell lines derived from single blastomeres. Nature 444, 481-485 (2006).
27. Simpson, J. L. Blastomeres and stem cells. Nature 444, 433-435 (2006).
28. 45 Code of Federal Regulations §46. 203 (b). [online], 〈http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm〉 (2005).
29. 45 Code of Federal Regulations §46. 406. [online], 〈http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm〉 (2005)
30. Deb, K., Sivaguru, M., Yong, H. Y. & Roberts, R. M. Cdx2 gene expression and trophectoderm lineage specification in mouse embryos. Science 311, 992-996 (2006).
31. Piotrowska-Nitsche, K., Perea-Gomez, A., Haraguchi, S. & Zernicka-Goetz, Z. Four-cell stage mouse blastomeres have different developmental properties. Development 132, 479-490 (2005).
32. Balanced Budget Downpayment Act I of 1996, Pub. L. No. 104-99, §128, 110 Stat. 26, 34. [online], 〈http://www.google. com/search?client=safari&rls=en&q= Balanced+Budget+Downpayment+Act+I+of+1996,&ie=UTF-8&oe= UTF-8〉 (1996).
33. Hudson, K. L. Preimplantation genetic diagnosis: public policy and public attitudes. Fertil. Steril. 85, 1638-1645 (2006).
34. Davis, D. S. The puzzle of IVF. Houst. J. Health Law Policy 6, 275-296 (2006).
35. Alberio, R., Campbell, K. H. & Johnson, A. D. Focus on stem cells: Reprogramming somatic cells into stem cells. Reproduction 132, 709-720 (2006).
36. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006).
37. Chief Medical Officer's Expert Group (UK). Stem Cell Research: Medical Progress with Responsibility, Department of Health, June 2000. [online], 〈http://www.dh.gov.uk/PublicationsAndStatistics/Publications/ PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en? CONTENT_ID=4065084&chk=IgquYC 〈http://www.dh.gov.uk/ PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/ PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4065084&chk= IgquYC〉 (2007).